Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of life saving
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    1301 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
    1302 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 55
    1303 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 26
    1304 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy NETHERLANDS 63
    1305 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 33
    1306 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy KAZAKHSTAN 10
    1307 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Italy 53
    1308 Apheresis Allogeneic Hodking Lymphoma Hematology 2025 Standard Therapy Belgium 62
    1309 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 54
    1310 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 66
    1311 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Spain 47
    1312 Apheresis Allogeneic T-Cell Lymphoma Hematology 2025 Standard Therapy Poland 25
    1313 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Portugal 62
    1314 Apheresis Autologous No Data Hematology 2025 Standard Therapy Portugal 65
    1315 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 38
    1316 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 60
    1317 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 65
    1318 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2025 Standard Therapy Germany 61
    1319 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 41
    1320 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 73
    1321 Apheresis Autologous T-Cell Lymphoma Hematology 2025 Standard Therapy Germany 49
    1322 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 61
    1323 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy United Kingdom 2
    1324 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 20
    1325 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 5
    1326 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2025 Standard Therapy USA 2
    1327 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Slovakia 56
    1328 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
    1329 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 60
    1330 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 64
    1331 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 42
    1332 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 63
    1333 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 59
    1334 Apheresis Allogeneic Myelodysplasia Hematology 2025 Standard Therapy Germany 47
    1335 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 58
    1336 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 76
    1337 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 55
    1338 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 70
    1339 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
    1340 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 51
    1341 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy United Kingdom 56
    1342 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Italy 62
    1343 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Norway 59
    1344 Apheresis Allogeneic Myeloid Sarcoma Hematology 2025 Standard Therapy Ukraine 24
    1345 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 63
    1346 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 58
    1347 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
    1348 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 68
    1349 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 71
    1350 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Sweden 62
    1351 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 5
    1352 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Turkey 2
    1353 Apheresis Allogeneic Hodgkin's Lymphoma (HL) Hematology 2025 Standard Therapy South Africa 38
    1354 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Poland 60
    1355 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 72
    1356 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy USA 59
    1357 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy NETHERLANDS 72
    1358 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 74
    1359 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 72
    1360 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 19
    1361 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 62
    1362 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Switzerland 25
    1363 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy USA 69
    1364 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 64
    1365 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Lithuania 55
    1366 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Greece 42
    1367 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy France 55
    1368 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 49
    1369 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 63
    1370 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Portugal 68
    1371 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 41
    1372 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 64
    1373 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 68
    1374 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 61
    1375 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 73
    1376 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 39
    1377 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 73
    1378 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russian Federation 57
    1379 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy BELARUS 22
    1380 Apheresis Allogeneic Other Leukemia Hematology 2025 Standard Therapy Belgium 60
    1381 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 48
    1382 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 20
    1383 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Lithuania 51
    1384 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
    1385 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Denmark 72
    1386 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 56
    1387 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 63
    1388 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 68
    1389 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 53
    1390 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 70
    1391 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 14
    1392 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 57
    1393 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Poland 49
    1394 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Russian Federation 43
    1395 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 76
    1396 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Belgium 63
    1397 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 63
    1398 Apheresis Allogeneic Other Leukemia, Specify, CNL Hematology 2025 Standard Therapy USA 70
    1399 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 53
    1400 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Iran 8